Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/30833
Title: Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients
Authors: Fracher Abramoff, Meire Maman
Fontana Lopes, Nilza Nelly [UNIFESP]
Lopes, Luciana Almeida
Dib, Luciano Lauria
Guilherme, Arnaldo
Caran, Eliana Monteiro [UNIFESP]
Barreto, Adriana Delboni
Martinho Lee, Maria Lucia [UNIFESP]
Petrilli, Antonio Sergio [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
NUPEN
Issue Date: 1-Aug-2008
Publisher: Mary Ann Liebert Inc
Citation: Photomedicine and Laser Surgery. New Rochelle: Mary Ann Liebert Inc, v. 26, n. 4, p. 393-400, 2008.
Abstract: Objective: A pilot clinical study was conducted to evaluate the efficacy and feasibility of low-level laser therapy (LLLT) in the prevention and treatment of chemotherapy (CT)-induced oral mucositis (OM) in young patients.Background Data: Besides compromising the patient's nutrition and well-being, oral mucositis represents a portal of entry into the body for microorganisms present in the mouth, which may lead to sepsis if there is hematological involvement. Oncologic treatment tolerance decreases and systemic complications may arise that interfere with the success of cancer treatment. LLLT appears to be an interesting alternative to other approaches to treating OM, due to its trophic, anti-inflammatory, and analgesic properties.Materials and Methods: Patients undergoing chemotherapy (22 cycles) without mucositis were randomized into a group receiving prophylactic laser-irradiation (group 1), and a group receiving placebo light treatment (group 2). Patients who had already presented with mucositis were placed in a group receiving irradiation for therapeutic purposes (group 3, with 10 cycles of CT). Serum granulocyte levels were taken and compared to the progression of mucositis.Results: in group 1, most patients (73%) presented with mucositis of grade 0 (p = 0.03 when compared with the placebo group), and 18% presented with grade 1. in group 2, 27% had no OM and did not require therapy. in group 3, the patients had marked pain relief (as assessed by a visual analogue scale), and a decrease in the severity of OM, even when they had severe granulocytopenia.Conclusion: the ease of use of LLLT, high patient acceptance, and the positive results achieved, make this therapy feasible for the prevention and treatment of OM in young patients.
URI: http://repositorio.unifesp.br/handle/11600/30833
ISSN: 1549-5418
Other Identifiers: http://dx.doi.org/10.1089/pho.2007.2144
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.